Whole Genome Study for Parkinson Disease
Lancet Neurol. 2006 Nov ;5(11):911-6. Abstract Katrina Gwinn-Hardy led this live discussion on 18
63 RESULTS
You searched 18.
Sort By:
Lancet Neurol. 2006 Nov ;5(11):911-6. Abstract Katrina Gwinn-Hardy led this live discussion on 18
of Neuroligin 1. 18 Oct 2012;76:410-422. Free Access at Cell Press Peixoto R, Kunz PA, Kwon H, Mabb
neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study. Molecular Psychiatry (2013), 1–8
Chem. 2002 Oct 25;277(43):40302-8. Epub 2002 Aug 20. Abstract 18. Dong J, Atwood CS, Anderson VE,
Leissring: Kalpana White has done the most work in this area. Torroja et al., J Neurosci 19(18):7793 is one.
knock-in mice were losing synapses. Beginning at 18 months, NL-F mice had trouble learning the location of
fluorine-18 (F-18) PIB compounds being used in human studies at Turku, Finland, and we are waiting to see
On 15 June 2009, we hosted a Webinar discussion with slide presentations by Ian McKeith at Newcastle University, UK, James Leverenz at University of Washington, Seattle, James Galvin, Washington University, St. Louis, Brit Mollenhauer of Paracelsus-Elena
Thierry Nouspikel led this live discussion on 14 July 2003. Readers are invited to submit additional comments by using our Comments form at the bottom of the page. Transcript: Dr. Thierry Nouspikel led this live discussion on 14 July 2003. Moderated by Dr
DCE-MRI scans of six healthy young people, 18 older folks who were cognitively normal, and 21 older adults
1999. 3: p. 65-70. Abstract 18. Sadovnick, A.D. and S. Lovestone, Ethical and legal issues: Genetic
2007 Sep 15;120(Pt 18):3157-61. No abstract available. Abstract 0 NS: Text requested September 12. NS:
This Webinar recapped the latest research in this area. Michael Heneka of the University of Bonn, Germany, and Doug Feinstein of the University of Illinois, Chicago, gave presentations, and were joined in a panel discussion by Virgil Muresan, New Jersey M
A Live Webinar Discussion was held on 29 October 2008, with presentations from Ilya Bezprozvanny, Beth Stutzmann, Kevin Foskett, Kim Green, and Brian Bacskai and Kishore Kuchibhotla. This live discussion began with a Webinar featuring a slide talk with au
18F-AV-45 (florbetapir F-18), an agent currently under consideration by the U.S. Food and Drug
Have a topic idea for a webinar? We would love to hear it. Send an email to webinars [at] alzforum [dot] org.